Prime Medicine raises $175M in one of the year's largest …
Prime initially aimed for a roughly $160 million IPO after raising more than $315 million in private financing, regulatory filings show. The company priced within its projected $16 to $18 per share range, but raised its IPO total by selling about 1.6 million more shares than intended, a sign of investor interest in the offering.